OACC Oaktree Acquisition Corp. III Life Sciences

Financial Services

$10.69-0.14%ClosedMarket Cap: $262.7M

As of 2026-05-26

Valuation

P/E (TTM)

35.75

PEG

—

P/B

1.05

P/S

0.00

EV/EBITDA

-216.80

DCF Value

—

FCF Yield

-0.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3.6%

ROA

3.4%

ROIC

-0.6%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 null	$0.00	NaN%	$-456.5K	$1.4M	$—	—
Q4 null	$0.00	NaN%	$-255.5K	$1.8M	$—	—
FY null	$0.00	NaN%	$-1.2M	$7.3M	$—	—
Q3 null	$0.00	NaN%	$-225.6K	$2.0M	$—	—
Q2 null	$0.00	NaN%	$-269.8K	$1.9M	$—	—
Q1 null	$0.00	NaN%	$-444.8K	$1.7M	$—	—
Q4 null	$0.00	NaN%	$-303.7K	$1.4M	$—	—
FY null	$0.00	NaN%	$-703.00	$2.7K	$—	—
Q3 null	$0.00	NaN%	$-48.1K	$-48.1K	$—	—